Gold tier: mechanically validated evidence, with its primary source.
682 evidence items · page 3 / 28
Two National Institutes of Health-funded primary stroke prevention trials included initial hydroxyurea treatment for children with sickle cell anemia and abnormal transcranial Doppler velocities in Nigeria.
Nigeriadrépanocytosepublished 2021Pediatric neurologyPubMeddocument of 4 observations
4.2 %The overall prevalence of subclinical hypothyroidism among children with sickle cell anaemia in this study was 4.2%.
Nigeriadrépanocytose · subclinical hypothyroidismpublished 2023Ethiopian journal of health sciencesPubMeddocument of 7 observations
98.9 %After a health education session, 98.9% of pregnant women understood that both parents must have at least one gene for someone to have sickle cell disease, compared to 77.5% before the session.
Nigeriadrépanocytosepublished 2024BMC pregnancy and childbirthPubMeddocument of 6 observations
42 patientsAmong the 257 enrolled sickle cell anaemia patients, 42 had proteinuric chronic kidney disease.
Nigeriadrépanocytose · proteinuric chronic kidney diseaseobserved January 2013 to April 2018published 2021Hematology/oncology and stem cell therapyPubMeddocument of 6 observations
33.3 %A third of the study participants (33.3%) expressed a contrary standpoint regarding prioritising sickle cell screening in their relationships.
Nigeriadrépanocytosepublished 2022Hematology (Amsterdam, Netherlands)PubMeddocument of 6 observations
65.5 %Among the 58 patients with sickle cell anemia, 65.5% were males.
Nigeriadrépanocytosepublished 2023Nigerian journal of clinical practicePubMeddocument of 9 observations
65 %The pediatric department (CHER+CHOP) recorded the highest proportion of sickle cell disease cases at 65%.
Nigeriadrépanocytoseobserved 2013 to 2014published 2022The Pan African medical journalPubMeddocument of 9 observations
1.16 cmSickle cell anemia subjects had a smaller mean inferior vena cava diameter than non-SCA subjects (1.16 cm ± 0.29 vs. 1.25 cm ± 0.33).
Nigeriadrépanocytosepublished 2023Nigerian journal of clinical practicePubMeddocument of 9 observations
73.4 %Three-quarters of the participants (73.4%) supported the need for contextual legislation to prohibit marriage between two sickle cell carriers.
Nigeriadrépanocytosepublished 2022Hematology (Amsterdam, Netherlands)PubMeddocument of 6 observations
2.7 x10¹²/LRed blood cell count in steady state subjects was 2.7 ± 0.4.
Nigeriadrépanocytosepublished 2022The Pan African medical journalPubMeddocument of 14 observations
72.4 %Isoelectric focusing (IEF) tests identified 370 (72.4%) HbAA, 133 (26.0%) HbAS, 5 (1.0%) HbSS, and 3 (0.6%) HbAC phenotypes among 511 newborns.
Nigeriadrépanocytosepublished 2022Frontiers in geneticseurope_pmcdocument of 23 observations
15.5 %Among 308 children with sickle cell disease in Nigeria, cerebral artery blood velocity was conditional in 48 (15.5%).
Nigeriadrépanocytosepublished 2023Archives of disease in childhoodPubMeddocument of 5 observations
The mean heart rate in crisis was higher than in steady state.
Nigeriadrépanocytosepublished 2020Cardiology in the youngPubMeddocument of 6 observations
52 %Abnormal LV geometry was detected in 52% of the SCA patients.
Nigeriadrépanocytosepublished 2026BMC cardiovascular disordersPubMeddocument of 6 observations
55.6 %Among 135 physicians caring for SCD patients in a southwestern state of Nigeria, 75 (55.6%) were willing to recommend the national government newborn screening program.
Nigeriadrépanocytosepublished 2020TheScientificWorldJournalPubMeddocument of 9 observations
73.6 %Among the healthcare workers, 39 (73.6%) were aware of Newborn Screening for Sickle Cell Disease.
Nigeriadrépanocytosepublished 2024Frontiers in public healtheurope_pmcdocument of 8 observations
No patients with chronic leg ulcer was diabetic.
Nigeriadiabète (non précisé) · drépanocytose · leg ulcersobserved 2015published 2020African journal of laboratory medicineeurope_pmcdocument of 3 observations
34,000 patientsOver 34,000 patients with sickle cell disease are enrolled in the SickleInAfrica consortium registry.
Nigeriadrépanocytosepublished 2025BMJ global healtheurope_pmcdocument of 4 observations
-0.1 correlation_coefficientBMI correlated negatively with left ventricular mass index (LVMI) among the subjects (r = -0.1, P = 0.53).
Nigeriadrépanocytosepublished 2021Nigerian journal of clinical practicePubMeddocument of 3 observations
0.24 %The estimated average birth prevalence of HbSC in Nigeria was 0.24%.
Nigeriadrépanocytosepublished 2021The Lancet. Haematologyeurope_pmcdocument of 6 observations
Myocardial ischaemia scores were higher in patients with crisis than in those in steady state.
Nigeriadrépanocytosepublished 2020Cardiology in the youngPubMeddocument of 6 observations
60 %The prevalence of ocular abnormalities among 120 children aged 5 to 15 years with sickle cell disease in steady state was 60.0%.
Nigeriadrépanocytosepublished 2021European journal of ophthalmologyPubMeddocument of 3 observations
23.6 yearsThe mean age of male patients with sickle cell disease in Ibadan, Nigeria, was 23.6 years with a standard deviation of 8.8 years.
Nigeriadrépanocytosepublished 2020West African journal of medicinePubMeddocument of 9 observations
10.8 %The prevalence of HbSC was 10.8% among sickle cell disease patients.
Nigeriadrépanocytose · HbSCpublished 2022Mediterranean journal of hematology and infectious diseaseseurope_pmcdocument of 17 observationsDOI 10.4084/mjhid.2022.001
1,213 casesOf the 7,256 children and adolescents with sickle cell disease, 1,213 (16.7%) had respiratory morbidities.
Nigeriadrépanocytose · respiratory morbiditiesobserved 2012 to 2021published 2024PloS onePubMeddocument of 12 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.